View Financial HealthElbstein 배당 및 자사주 매입배당 기준 점검 4/6Elbstein 은(는) 현재 수익률이 4.55% 인 배당금 지급 회사입니다.핵심 정보4.5%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Aug 20Upcoming dividend of €0.05 per shareEligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%).모든 업데이트 보기Recent updates공시 • Apr 21Elbstein AG, Annual General Meeting, May 29, 2026Elbstein AG, Annual General Meeting, May 29, 2026, at 10:00 W. Europe Standard Time.Buy Or Sell Opportunity • Mar 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 33% to €0.70. The fair value is estimated to be €0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Feb 05Now 24% overvaluedOver the last 90 days, the stock has fallen 8.3% to €1.10. The fair value is estimated to be €0.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only.공시 • Aug 13Elbstein AG, Annual General Meeting, Sep 19, 2025Elbstein AG, Annual General Meeting, Sep 19, 2025, at 11:00 W. Europe Standard Time.Buy Or Sell Opportunity • Aug 12Now 73% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to €1.45. The fair value is estimated to be €0.84, however this is not to be taken as a sell recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Jul 09Now 44% overvalued after recent price riseOver the last 90 days, the stock has risen 138% to €1.19. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only.New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (€13.5m market cap, or US$15.9m).New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (€110k revenue, or US$114k). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$15.6m).공시 • Jul 29Elbstein AG, Annual General Meeting, Sep 04, 2024Elbstein AG, Annual General Meeting, Sep 04, 2024, at 11:00 W. Europe Standard Time.New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (42% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€21.0m market cap, or US$22.5m).New Risk • May 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Revenue has declined by 98% over the past year. Revenue is less than US$1m (€2.4k revenue, or US$2.6k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€15.0m market cap, or US$16.3m).Buy Or Sell Opportunity • May 22Now 32% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.0% to €0.50. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 02Now 30% undervaluedOver the last 90 days, the stock has risen 34% to €0.51. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.Buying Opportunity • Jan 11Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.New Risk • Dec 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.50m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (43% average weekly change). Market cap is less than US$10m (€7.50m market cap, or US$8.06m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buying Opportunity • Nov 18Now 54% undervalued after recent price dropOver the last 90 days, the stock is down 25%. The fair value is estimated to be €0.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only.New Risk • Oct 12New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.30m (US$9.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€9.30m market cap, or US$9.81m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buying Opportunity • Aug 01Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 65%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buying Opportunity • Jul 12Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.New Risk • Jul 02New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€27.0m market cap, or US$29.5m).Buying Opportunity • Jun 15Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 96% over the last year. Earnings per share has declined by 33%.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €1.20, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.Valuation Update With 7 Day Price Move • Apr 26Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €1.30, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total loss to shareholders of 9.8% over the past three years.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €1.54, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.15, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 23% over the past three years.Valuation Update With 7 Day Price Move • Dec 06Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to €1.21, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 17% over the past three years.Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €1.50, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 4.1% over the past three years.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to €1.60, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 10% over the past three years.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to €1.55, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 6.9% over the past three years.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.20, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 50% over the past three years.Valuation Update With 7 Day Price Move • May 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.06, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 14x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment deteriorated over the past weekAfter last week's 28% share price decline to €2.10, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 16x in the Capital Markets industry in Germany. Total returns to shareholders of 66% over the past three years.Upcoming Dividend • Aug 20Upcoming dividend of €0.05 per shareEligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%).Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to €2.90, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 20x in the Capital Markets industry in Germany. Total returns to shareholders of 99% over the past three years.분석 기사 • Jul 02Unpleasant Surprises Could Be In Store For Elbstein AG's (HMSE:EBS) SharesWith a median price-to-earnings (or "P/E") ratio of close to 26x in Germany, you could be forgiven for feeling...Reported Earnings • Jun 29Full year 2020 earnings releasedThe company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: €3.52m (up €3.11m from FY 2019). Net income: €2.83m (up 273% from FY 2019). Profit margin: 80% (down from 186% in FY 2019). The decrease in margin was primarily driven by higher revenue.Valuation Update With 7 Day Price Move • Mar 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €2.00, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 62.8x. This compares to an average P/E of 21x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 56%.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €2.20, the stock is trading at a trailing P/E ratio of 58x, down from the previous P/E ratio of 68.6x. This compares to an average P/E of 19x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 79%.Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.20, the stock is trading at a trailing P/E ratio of 58x, up from the previous P/E ratio of 48.8x. This compares to an average P/E of 17x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 71%.Is New 90 Day High Low • Jan 15New 90-day high: €2.04The company is up 40% from its price of €1.46 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 33% share price gain to €2.00, the stock is trading at a trailing P/E ratio of 5.3x, up from the previous P/E ratio of 4x. This compares to an average P/E of 15x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 52%.Is New 90 Day High Low • Oct 02New 90-day low: €14.50The company is down 6.0% from its price of €15.50 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is down 10.0% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: EBS 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.배당금 증가: EBS 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Elbstein 배당 수익률 vs 시장EBS의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (EBS)4.5%시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Capital Markets)2.9%분석가 예측 (EBS) (최대 3년)n/a주목할만한 배당금: EBS 의 배당금( 4.55% )은 German 시장에서 배당금 지급자의 하위 25%( 1.52% )보다 높습니다.고배당: EBS 의 배당금( 4.55% )은 German 시장( 4.52% )주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 EBS 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 배당금 지급이 현금 흐름에 의해 충당되는지 판단하기 위해 EBS 의 현금 지급 비율을 계산하기에는 데이터가 부족합니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 12:04종가2026/05/20 00:00수익2023/12/31연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Elbstein AG는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Upcoming Dividend • Aug 20Upcoming dividend of €0.05 per shareEligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%).
공시 • Apr 21Elbstein AG, Annual General Meeting, May 29, 2026Elbstein AG, Annual General Meeting, May 29, 2026, at 10:00 W. Europe Standard Time.
Buy Or Sell Opportunity • Mar 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 33% to €0.70. The fair value is estimated to be €0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Feb 05Now 24% overvaluedOver the last 90 days, the stock has fallen 8.3% to €1.10. The fair value is estimated to be €0.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
공시 • Aug 13Elbstein AG, Annual General Meeting, Sep 19, 2025Elbstein AG, Annual General Meeting, Sep 19, 2025, at 11:00 W. Europe Standard Time.
Buy Or Sell Opportunity • Aug 12Now 73% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to €1.45. The fair value is estimated to be €0.84, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Jul 09Now 44% overvalued after recent price riseOver the last 90 days, the stock has risen 138% to €1.19. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (€13.5m market cap, or US$15.9m).
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (€110k revenue, or US$114k). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$15.6m).
공시 • Jul 29Elbstein AG, Annual General Meeting, Sep 04, 2024Elbstein AG, Annual General Meeting, Sep 04, 2024, at 11:00 W. Europe Standard Time.
New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (42% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€21.0m market cap, or US$22.5m).
New Risk • May 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Revenue has declined by 98% over the past year. Revenue is less than US$1m (€2.4k revenue, or US$2.6k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€15.0m market cap, or US$16.3m).
Buy Or Sell Opportunity • May 22Now 32% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.0% to €0.50. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 02Now 30% undervaluedOver the last 90 days, the stock has risen 34% to €0.51. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.
Buying Opportunity • Jan 11Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.
New Risk • Dec 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.50m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (43% average weekly change). Market cap is less than US$10m (€7.50m market cap, or US$8.06m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buying Opportunity • Nov 18Now 54% undervalued after recent price dropOver the last 90 days, the stock is down 25%. The fair value is estimated to be €0.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
New Risk • Oct 12New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.30m (US$9.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€9.30m market cap, or US$9.81m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buying Opportunity • Aug 01Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 65%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buying Opportunity • Jul 12Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
New Risk • Jul 02New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€27.0m market cap, or US$29.5m).
Buying Opportunity • Jun 15Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 96% over the last year. Earnings per share has declined by 33%.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €1.20, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €1.30, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total loss to shareholders of 9.8% over the past three years.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €1.54, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.
Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.15, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 23% over the past three years.
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to €1.21, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 17% over the past three years.
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €1.50, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 4.1% over the past three years.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to €1.60, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 10% over the past three years.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to €1.55, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 6.9% over the past three years.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.20, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 50% over the past three years.
Valuation Update With 7 Day Price Move • May 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.06, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 14x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment deteriorated over the past weekAfter last week's 28% share price decline to €2.10, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 16x in the Capital Markets industry in Germany. Total returns to shareholders of 66% over the past three years.
Upcoming Dividend • Aug 20Upcoming dividend of €0.05 per shareEligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%).
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to €2.90, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 20x in the Capital Markets industry in Germany. Total returns to shareholders of 99% over the past three years.
분석 기사 • Jul 02Unpleasant Surprises Could Be In Store For Elbstein AG's (HMSE:EBS) SharesWith a median price-to-earnings (or "P/E") ratio of close to 26x in Germany, you could be forgiven for feeling...
Reported Earnings • Jun 29Full year 2020 earnings releasedThe company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: €3.52m (up €3.11m from FY 2019). Net income: €2.83m (up 273% from FY 2019). Profit margin: 80% (down from 186% in FY 2019). The decrease in margin was primarily driven by higher revenue.
Valuation Update With 7 Day Price Move • Mar 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €2.00, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 62.8x. This compares to an average P/E of 21x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 56%.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €2.20, the stock is trading at a trailing P/E ratio of 58x, down from the previous P/E ratio of 68.6x. This compares to an average P/E of 19x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 79%.
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.20, the stock is trading at a trailing P/E ratio of 58x, up from the previous P/E ratio of 48.8x. This compares to an average P/E of 17x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 71%.
Is New 90 Day High Low • Jan 15New 90-day high: €2.04The company is up 40% from its price of €1.46 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 33% share price gain to €2.00, the stock is trading at a trailing P/E ratio of 5.3x, up from the previous P/E ratio of 4x. This compares to an average P/E of 15x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 52%.
Is New 90 Day High Low • Oct 02New 90-day low: €14.50The company is down 6.0% from its price of €15.50 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is down 10.0% over the same period.